The performances of the Cockcroft-Gault, Modification of Diet in Renal Disease study and Chronic Kidney Disease Epidemiology Collaboration equations in predicting gentamicin clearance

Annals of Clinical Biochemistry

Volumn 50, Issue 6, 2013, Pages 546-557

  Chin, P K L ^a,b   Florkowski, C M ^c   Begg, E J ^a,b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

Analytes; Clinical studies; Creatinine; Pharmacokinetics; Renal disease

Indexed keywords

CREATININE; GENTAMICIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BODY MASS; BODY SIZE; BODY SURFACE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION; CLINICAL ASSESSMENT; COCKCROFT GAULT MODEL; COMPARTMENT MODEL; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISTRIBUTION VOLUME; DRUG CLEARANCE; FEMALE; HUMAN; ISOTOPE DILUTION MASS SPECTROMETRY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATHEMATICAL MODEL; MODIFICATION OF DIET IN RENAL DISEASE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY;

ANALYTES; CLINICAL STUDIES; CREATININE; PHARMACOKINETICS; RENAL DISEASE;

ADOLESCENT; ADULT; AGED; COOPERATIVE BEHAVIOR; CREATININE; DIET; FEMALE; GENTAMICINS; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84884691365     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213492320     Document Type: Article

References (44)

1. Begg EJ and Chin PK. A unified pharmacokinetic approach to individualized drug dosing. Br J Clin Pharmacol 2012; 73: 335-339.
2. Doogue MP and Polasek TM. Drug dosing in renal disease. Clin Biochem Rev 2011; 32: 69-73.
3. Matzke GR, Aronoff GR, Atkinson AJ Jr, et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011; 80: 1122-1137.
4. Cockcroft DW and Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
5. Lalonde RL and Wagner JA. Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment. Clin Pharmacol Ther 2009; 86: 557-561.
6. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
7. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
8. Florkowski CM and Chew-Harris JS. Methods of estimating GFR-different equations including CKD-EPI. Clin Biochem Rev 2011; 32: 75-79.
9. Spruill WJ, Wade WE and Cobb HH III. Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function. Clin Pharmacol Ther 2009; 86: 468-470.
10. Stevens LA and Levey AS. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther 2009; 86: 465-467.
11. Begg EJ and Barclay ML. Aminoglycosides-50 years on. Br J Clin Pharmacol 1995; 39: 597-603.
12. Avent ML, Rogers BA, Cheng AC, et al. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. Intern Med J 2011; 41: 441-449.
13. Begg EJ, Barclay ML and Duffull SB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 1995; 39: 605-609.
14. Duffull SB, Kirkpatrick CM and Begg EJ. Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens. Br J Clin Pharmacol 1997; 43: 125-135.
15. Bookstaver PB, Johnson JW, McCoy TP, et al. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination. Ann Pharmacother 2008; 42: 1758-1765.
16. Roberts GW, Ibsen PM and Schioler CT. Modified diet in renal disease method overestimates renal function in selected elderly patients. Age Ageing 2009; 38: 698-703.
17. Ryzner KL. Evaluation of aminoglycoside clearance using the modification of diet in renal disease equation versus the Cockcroft-Gault equation as a marker of glomerular filtration rate. Ann Pharmacother 2010; 44: 1030-1037.
18. Pai MP, Nafziger AN and Bertino JS Jr. Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients. Antimicrob Agents Chemother 2011; 55: 4006-4011.
19. Kirkpatrick CM, Duffull SB and Begg EJ. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br J Clin Pharmacol 1999; 47: 637-643.
20. Zaske DE, Cipolle RJ, Rotschafer JC, et al. Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations. Antimicrob Agents Chemother 1982; 21: 407-411.
21. Reinhard M, Erlandsen EJ and Randers E. Biological variation of cystatin C and creatinine. Scand J Clin Lab Invest 2009; 69: 831-836.
22. Pai MP and Paloucek FP. The origin of the "ideal" body weight equations. Ann Pharmacother 2000; 34: 1066-1069.
23. Winter MA, Guhr KN and Berg GM. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy 2012; 32: 604-612.
24. Spinler SA, Nawarskas JJ, Boyce EG, et al. Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group. Ann Pharmacother 1998; 32: 1275-1283.
25. Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44: 1051-1065.
26. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098.
27. Stevens LA, Nolin TD, Richardson MM, et al. Comparison of drug dosing recommendations based on measured GFR and kidney function estimating equations. Am J Kidney Dis 2009; 54: 33-42.
28. Bland JM and Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
29. Zarowitz BJ, Robert S and Peterson EL. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Ann Pharmacother 1992; 26: 1205-1210.
30. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
31. Moranville MP and Jennings HR. Implications of using modification of diet in renal disease versus Cockcroft-Gault equations for renal dosing adjustments. Am J Health Syst Pharm 2009; 66: 154-161.
32. Brunton L, Brunton LL, Chabner B, et al. Goodman and Gilman's the pharmacological basis of therapeutics, 12th ed. New York, NY: McGraw-Hill, 2010.
33. Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother 1995; 39: 650-655.
34. Mathew TH. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005; 183: 138-141.
35. Mathew TH, Johnson DW and Jones GR. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007; 187: 459-463.
36. Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med 2012; 156: 785-795.
37. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
38. Johnson DW, Jones GR, Mathew TH, et al. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust 2012; 197: 222-223.
39. Jones GR. Estimating renal function for drug dosing decisions. Clin Biochem Rev 2011; 32: 81-88.
40. 2. Am J Kidney Dis 2010; 56: 486-495.
41. Udy AA, Roberts JA, Boots RJ, et al. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet 2010; 49: 1-16.
42. Chin PK, Vella-Brincat JW, Barclay ML, et al. Perspective on dabigatran etexilate dosing: why not follow standard pharmacological principles? Br J Clin Pharmacol 2012; 74: 734-740.
43. Park EJ, Pai MP, Dong T, et al. The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults. Ann Pharmacother 2012; 46: 317-328.
44. Duffull SB, Begg EJ, Robinson BA, et al. A sequential Bayesian algorithm for dose individualisation of carboplatin. Cancer Chemother Pharmacol 1997; 39: 317-326.